New Technologies, Products, Companies, Markets and Opportunities in Med/Surg Wound Closure

June 18, 2012 - PRLog -- Advanced products for the effective management of medical and surgical wounds encompass hemostatic agents, fibrin and other sealants, high strength medical adhesives and even products to prevent post-surgical adhesions.  These products provide active roles biologically in accelerating and optimizing wound healing. Alternatively, traditional products and technologies, such as sutures, tapes and, more recently, staples, clips and other mechanical wound closure, play a role in wound management that is largely limited to physically juxtaposing wound edges in order to enable the body’s natural wound healing processes to occur across a minimal gap.     

“The use of sutures, tapes and other physical wound closure dates back arguably thousands of years, and while a great many wound types can be adequately managed by these wound products, considerable opportunity exists for new products, whether used alone or adjunctively with traditional products, to accelerate wound healing, minimize blood loss, minimize infection and otherwise reduce the overall cost of healing wounds,” notes Patrick Driscoll, MedMarket Diligence, publisher of the 2012 report, “Worldwide Surgical Sealants, Glues, Wound Closure and Anti-Adhesion Markets, 2010-2017.”

According to Driscoll, advanced wound closure technologies including sealants and adhesives have created about a $2 billion dent in the roughly $7 billion current worldwide wound closure market.  And with sealants/adhesives growing at better than 10% annually while sutures, staples, clips and tapes sales are only growing at 5-7% annually, the impact of new closure technologies becomes greater every year.

The MedMarket Diligence 2012 report (see http://www.mediligence.com/rpt/rpt-s190.htm) assesses the global market to reveal the size, outlook and opportunities for current and hopeful competitors developing and marketing the spectrum of sealants & glues technologies used in traumatic, surgical and other wound closure, including tapes, sutures/staples/mechanical closure, hemostats, fibrin sealants/glues and high-strength medical adhesives and anti-adhesion products.  The report details current clinical and technology developments, with data on products in development (detailing market status) and on the market; market size and forecast; competitor market shares; competitor profiles; and market opportunity. The report provides full year historical actual data for 2010 and 2011 and forecast 2012-2017 of the markets for these technologies, with emphasis on the market impact of new technologies through the forecast period. The report provides specific forecasts and shares of the worldwide market by segment for Americas (detail for U.S., Rest of North America and Latin America), Europe (detail for United Kingdom, Germany, France, Italy, Spain, Rest of Europe), Asia/Pacific (detail for Japan, Korea, Rest of Asia/Pacific) and Rest of World.

The report provides background data on the surgical, disease and traumatic wound patient populations targeted by current technologies and those under development, and the current clinical practices in the management of these patients, including the dynamics among the various clinical specialties or subspecialties vying for patient population and facilitating or limiting the growth of technologies. The report establish the current worldwide market size for major technology segments as a baseline for and projecting growth in the market through 2017. The report assesses and projects the composition of the market as technologies gain or lose relative market performance over this period. The report profiles 122 active companies in this industry, providing data on their current products, current market position and products under development.

The report is described in detail at http://www.mediligence.com/rpt/rpt-s190.htm.

The report may be purchased for immediate download at http://www.mediligence.com/store/page43.html.